Cookies Policy
X

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Herpes simplex virus type 1/adeno-associated virus hybrid vectors

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

Access this article

+ Tax (if applicable)
Add to Favorites
You must be logged in to use this functionality

image of Gene Therapy and Regulation

Herpes simplex virus type 1 (HSV-1) amplicons can accommodate foreign DNA of any size between 1 kbp and 150 kbp and, therefore, give room for almost unlimited combinations of genetic elements. Genomic sequences as well as cDNA, large transcriptional regulatory sequences for cell type-specific expression, multiple transgenes, and genetic elements from other viruses to create hybrid vectors may be inserted in a modular fashion. Hybrid amplicons use genetic elements from HSV-1 that allow replication and packaging of the vector DNA into HSV-1 virions, and genetic elements from other viruses that either direct integration of transgene sequences into the host genome or allow the vector to replicate autonomously as an episome. Thus, the advantages of the HSV-1 amplicon system, such as large transgene capacity, broad host range, strong nuclear localization, and availability of a helper virus-free packaging system are retained and combined with those of heterologous viral elements that confer genetic stability to the vector DNA within transduced cells. In this respect, adeno-associated virus (AAV) has the unique capability of integrating its genome into a specific site, designated AAVS1, on human chromosome 19. The viral rep gene and the inverted terminal repeats (ITRs) that flank the AAV genome are sufficient for this process. HSV-1 amplicons have thus been designed that incorporate the AAV rep gene on the backbone and the AAV ITRs on the bondaries of the transgene cassette. These HSV/AAV hybrid vectors direct site-specific integration of transgene sequences into AAVS1 and support long-term transgene expression. Optimization of these hybrid vectors is discussed in terms of elimination of both background random-integration and rep interference on vector packaging.

10.1163/156855803762295404
/content/journals/10.1163/156855803762295404
dcterms_title,pub_keyword,dcterms_description,pub_author
6
3
Loading
Loading

Full text loading...

/content/journals/10.1163/156855803762295404
Loading

Data & Media loading...

http://brill.metastore.ingenta.com/content/journals/10.1163/156855803762295404
Loading

Article metrics loading...

/content/journals/10.1163/156855803762295404
2003-03-01
2016-12-11

Sign-in

Can't access your account?
  • Tools

  • Add to Favorites
  • Printable version
  • Email this page
  • Subscribe to ToC alert
  • Get permissions
  • Recommend to your library

    You must fill out fields marked with: *

    Librarian details
    Your details
    Why are you recommending this title?
    Select reason:
     
    Gene Therapy and Regulation — Recommend this title to your library
  • Export citations
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation